Fexofenadine-induced QT prolongation: a myth or fact?
- 1 June 2000
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 142 (6) , 1260-1261
- https://doi.org/10.1046/j.1365-2133.2000.03576.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Cardiovascular Safety of FexofenadineHClThe American Journal of Cardiology, 1999
- QT lengthening and life-threatening arrhythmias associated with fexofenadineThe Lancet, 1999
- Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performanceJournal of Allergy and Clinical Immunology, 1998
- FexofenadineDrugs, 1998
- Onset of Action, Efficacy, and Safety of a Single Dose of Fexofenadine Hydrochloride for Ragweed Allergy Using an Environmental Exposure UnitAnnals of Allergy, Asthma & Immunology, 1997
- Terfenadine-Ketoconazole InteractionJAMA, 1993
- Mechanism of the cardiotoxic actions of terfenadineJAMA, 1993
- Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequencesJAMA, 1993
- Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycinClinical Pharmacology & Therapeutics, 1992